Powers Advisory Group’s Medtronic MDT Stock Holding History

Powers Advisory Group’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$226K	Sell	2,895 -479	-14%	-$38.6K	0.07%	125
2026 Q1	$292K	Sell	3,374 -145	-4%	-$13.9K	0.1%	105
2025 Q4	$338K	Hold	3,519	–	–	0.13%	91
2025 Q3	$335K	Sell	3,519 -322	-8%	-$29.6K	0.13%	89
2025 Q2	$335K	Sell	3,841 -50	-1%	-$4.24K	0.15%	87
2025 Q1	$350K	Buy	3,891 +289	+8%	+$25.9K	0.17%	80
2024 Q4	$288K	Hold	3,602	–	–	0.14%	83
2024 Q3	$324K	Sell	3,602 -25	-0.7%	-$2.1K	0.16%	79
2024 Q2	$285K	Hold	3,627	–	–	0.16%	84
2024 Q1	$316K	Buy	3,627 +821	+29%	+$70.1K	0.18%	77
2023 Q4	$231K	Buy	+2,806	New	+$214K	0.14%	87

Other funds holding MDT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Powers Advisory Group's MDT Position: Q2 2026 in Review

Powers Advisory Group reduced its Medtronic (MDT) stake by 14% in Q2 2026, selling an estimated $38.6K and leaving 2,895 shares worth $226K. The position accounts for 0.07% of the portfolio, ranked #125.

Powers Advisory Group first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $350K in Q1 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

Powers Advisory Group held 2,895 shares of Medtronic worth $226K as of Q2 2026.
Powers Advisory Group sold 479 Medtronic shares in Q2 2026, an estimated $38.6K.
Medtronic made up 0.07% of Powers Advisory Group's portfolio in Q2 2026, its #125 holding.
Powers Advisory Group first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
Powers Advisory Group's Medtronic position peaked at $350K in Q1 2025.
2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Powers Advisory Group's 13F filing for Q2 2026, filed 31 Jul 2026.